|
Business Account Executive, TTR - West Palm, FL
|
Cambridge, MA, US, 02142
|
Mar 18, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Wisconsin
|
Cambridge, MA, US, 02142
|
Mar 18, 2026
|
Full-Time
|
|
|
Combination Product Engineer III
|
Cambridge, MA, US, 02142
|
Apr 7, 2026
|
Full-Time
|
|
|
Country Medical Director
|
Mississauga, ON, CA, L4Z 1S1
|
Mar 28, 2026
|
Full-Time
|
|
|
Director, Advanced Analytics - Business Performance
|
Cambridge, MA, US, 02142
|
Mar 20, 2026
|
Full-Time
|
|
|
Director, Advanced Analytics - Customer & Account Growth
|
Cambridge, MA, US, 02142
|
Mar 20, 2026
|
Full-Time
|
|
|
Director, Antibody Downstream Development
|
Cambridge, MA, US, 02142
|
Mar 20, 2026
|
Full-Time
|
|
|
Director, Clinical Operations
|
Cambridge, MA, US, 02142
|
Apr 1, 2026
|
Full-Time
|
|
|
Director, Clinical Research-Cardiology
|
Philadelphia, PA, US, 19104
+1 more…
|
Mar 21, 2026
|
Full-Time
|
|
|
Director, Commercial Global Compensation
|
Cambridge, MA, US, 02142
|
Mar 27, 2026
|
Full-Time
|
|
|
Director, Commercial Planning & Strategic Initiatives
|
Cambridge, MA, US, 02142
|
Apr 1, 2026
|
Full-Time
|
|
|
Director, Commercial Training and Development
|
Cambridge, MA, US, 02142
|
Apr 7, 2026
|
Full-Time
|
|
|
Director, Data Engineering & Management TOQ & ReDev
|
Cambridge, MA, US, 02142
|
Apr 2, 2026
|
Full-Time
|
|
|
Director, Development Strategy & Operations
|
Cambridge, MA, US, 02142
|
Apr 4, 2026
|
Full-Time
|
|
|
Director, Epidemiology
|
Cambridge, MA, US, 02142
|
Mar 21, 2026
|
Full-Time
|
|
|
Director, Field Reimbursement Lead - Central
|
Cambridge, MA, US, 02142
|
Apr 14, 2026
|
Full-Time
|
|
|
Director, Field Reimbursement Lead - Northeast
|
Cambridge, MA, US, 02142
|
Mar 24, 2026
|
Full-Time
|
|
|
Director, Field Reimbursement Lead - West
|
Cambridge, MA, US, 02142
|
Apr 8, 2026
|
Full-Time
|
|
|
Director, Financial Planning & Analysis, Business Development
|
Cambridge, MA, US, 02142
|
Mar 27, 2026
|
Full-Time
|
|
|
Director, G&A, Data & Software Engineering
|
Cambridge, MA, US, 02142
|
Apr 3, 2026
|
Full-Time
|
|